International Scholars

The World Immunotherapy Council—a collaborative group of more than 20 organizations from the U.S. and abroad with a shared interest in promoting research and translation of cancer immunotherapy—selected the young investigators below to present during the 2nd World Immunotherapy Council Young Investigators Symposium, part of SITC’s 32nd Annual Meeting & Pre-Conference Programs in 2017.

Chosen for exemplary work in the field, these scholars contributed insights and perspectives into future issues, challenges and improvements as cancer immunotherapy is integrated into mainstream cancer treatment.

2017 International Scholars

Covre_NIBIT_2.jpg

Sarah_Crome.jpg

Alessia Covre, PhD
NIBIT Foundation (Network Italiano per la Bioterapia dei Tumori)
Italy

Sarah Crome, PhD
Canadian Cancer Immunotherapy Consortium
Canada

Czirbesz__Katalin_2.jpg

Liang_Deng_Photo.jpg

Katalin Czirbesz, MD
National Institute of Oncology, Budapest
Hungary

Liang Deng, MD, PhD
Chinese American Hematology Oncology Network (CAHON)
China

Fang_Fang.jpg

Erica_Fletcher.jpg

Fang Fang, PhD
Chinese Society of Immunology (CSI)
China

Erika Fletcher, PhD
Scandinavian Network for Immunotherapy of Cancer (SNIC)
Sweden

Fowler__Daniel.jpg

Celia_Jacoberger-Foissac.jpg

Daniel William Fowler, PhD
Institute for Cancer Vaccines and Immunotherapy (ICVI)
United Kingdom

Célia Jacoberger-Foissac, MSc
Cancer Drug Development Forum (Biotherapy Development Association)
Belgium

A__Kamphorst.jpg

Karasaki__Takahiro.jpg

Alice O. Kamphorst, PhD
Cancer Research Institute (CRI)
United States

Takahiro Karasaki, MD
Japanese Association of Cancer Immunology (JACI)
Japan

SITC_photo.jpg

Lennicke__Claudia.png

Jan Willem Kleinovink, PhD
Dutch Tumor Immunology Working Party (DTIWP)
Netherlands

Claudia Lennicke, PhD
Tumor Immunology Meets Oncology (TIMO)
Germany

Gitte_Holmen_Olofsson.jpg

Owens__Gemma.jpg

Gitte Holmen Olofsson
Progress in Vaccination Against Cancer (PIVAC)
Denmark

Gemma Owens, MBBCh
Adaptive Engineered T Cell Targeting to Active Cancer Killing (ATTACK)
United Kingdom

Zappasodi1.jpg

Roberta Zappasodi, PhD
Society for Immunotherapy of Cancer (SITC)
United States